Coffee, glucose homeostasis, and insulin resistance: Physiological mechanisms and mediators

Applied Physiology, Nutrition and Metabolism

Volumn 33, Issue 6, 2008, Pages 1290-1300

  Tunnicliffe, Jasmine M ^a   Shearer, Jane ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Beverage; Caffeine; Diet; Nutrition; Type 2 diabetes

Indexed keywords

ANTIOXIDANT; CAFFEINE; CENTRAL STIMULANT AGENT;

ANIMAL; CHEMISTRY; COFFEE; CONFERENCE PAPER; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; COFFEE; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MICE;

EID: 57649194754     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H08-123     Document Type: Conference Paper

References (125)

1. Adrian, J., and Frangne, R. 1991. Synthesis and availability of niacin in roasted coffee. Adv. Exp. Med. Biol. 289: 49-59. PMID:1897406.
2. Albano, E. 2006. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 65: 278-290. doi:10.1079/PNS2006496. PMID:16923312.
3. Almeida, A.A., Farah, A., Silva, D.A., Nunan, E.A., and Gloria, M.B. 2006. Antibacterial activity of coffee extracts and selected coffee chemical compounds against enterobacteria. J. Agric. Food Chem. 54: 8738-8743. doi:10.1021/jf0617317. PMID:17090115.
4. Anini, Y., and Brubaker, P.L. 2003. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes, 52: 252-259. doi:10.2337/diabetes.52.2.252. PMID:12540594.
5. Arya, M., and Rao, L. 2007. An impression of coffee carbohydrates. Crit. Rev. Food. Sci. Nurtr. 47: 51-67. doi:10.1080/10408390600550315. PMID:17364695.
6. Astrup, A., Toubro, S., Cannon, S., Hein, P., Breum, L., and Madsen, J. 1990. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am. J. Clin. Nutr. 51: 759-767. PMID:2333832.
7. Astrup, A., Breum, L., Toubro, S., Hein, P., and Quaade, F. 1992. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. Int. J. Obes. Relat. Metab. Disord. 16: 269-277. PMID:1318281.
8. Azam, S., Hadi, N., Khan, N.U., and Hadi, S.M. 2003. Antioxidant and prooxidant properties of caffeine, theobromine and xanthine. Med. Sci. Monit. 9: BR325-BR330. PMID:12960921.
9. Baggio, L.L., and Drucker, D.J. 2007. Biology of incretins: GLP-1 and GIP. Gastroenterology, 132: 2131-2157. doi:10.1053/j.gastro.2007.03.054. PMID:17498508.
10. Battram, D.S., Graham, T.E., Richter, E.A., and Dela, F. 2005. The effect of caffeine on glucose kinetics in humans - influence of adrenaline. J. Physiol. 569: 347-355. doi:10.1113/jphysiol.2005.097444. PMID:16150793.
11. Battram, D.S., Arthur, R., Weekes, A., and Graham, T.E. 2006. The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men. J. Nutr. 136: 1276-1280. PMID:16614416.
12. Bhathena, S.J., and Velasquez, M.T. 2002. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 76: 1191-1201. PMID:12450882.
13. Bracco, D., Ferrarra, J.M., Arnaud, M.J., Jequier, E., and Schutz, Y. 1995. Effects of caffeine on energy metabolism, heart rate, and methylxanthine metabolism in lean and obese women. Am. J. Physiol. 269: E671-E678. PMID:7485480.
14. Burke L.M. 2008. Caffeine and sports performance. Appl. Physiol. Nutr. Metab. 33: this issue.
15. Butterfield, D.A., Perluigi, M., and Sultana, R. 2006. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 545: 39-50. doi:10.1016/j.ejphar.2006.06.026. PMID:16860790.
16. Coffee Association of Canada. 2003. Highlights: 2003 Canadian Coffee Drinking Study. Available from http://www.coffeeassoc.com/coffeeincanada.htm. [Accessed 15 October 2008.]
17. Canadian Diabetes Association. 2003. Clinical Practice Guidelines. Pharmacological Management of Type 2 Diabetes. Available from http://www.diabetes.ca/cpg2003/chapters.aspx? pharmacologicmanagementoftype2diabetes.htm. [Accessed 15 October 2008.]
18. Cani, P.D., Amar, J., Iglesias, M.A., Poggi, M., Knauf, C., Bastelica, D., et al. 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes, 56: 1761-1772. doi:10.2337/db06-1491. PMID:17456850.
19. Cani, P.D., Hoste, S., Guiot, Y., and Delzenne, N.M. 2007b. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br. J. Nutr. 98: 32-37. doi:10.1017/ S0007114507691648. PMID:17367575.
20. Cani, P.D., Neyrinck, A.M., Fava, F., Knauf, C., Burcelin, R.G., Tuohy, K.M., et al. 2007c. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383. PMID:17823788.
21. Casal, S., Oliveira, M.B., Alves, M.R., and Ferreira, M.A. 2000. Discriminate analysis of roasted coffee varieties for trigonelline, nicotinic acid, and caffeine content. J. Agric. Food Chem. 48: 3420-3424. doi:10.1021/jf990702b. PMID:10956127.
22. Casiglia, E., Spolaore, P., Ginocchio, G., and Ambrosio, G.B. 1993. Unexpected effects of coffee consumption on liver enzymes. Eur. J. Epidemiol. 9: 293-297. doi:10.1007/BF00146266. PMID:8104822.
23. Cheung, W.T., Lee, C.M., and Ng, T.B. 1988. Potentiation of the anti-lipolytic effect of 2-chloroadenosine after chronic caffeine treatment. Pharmacology, 36: 331-339. doi:10.1159/000138403. PMID:3406045.
24. Chipkin, S.R. 2005. How to select and combine oral agents for patients with type 2 diabetes mellitus. Am. J. Med. 118(Suppl 5A): 4S-13S. doi:10.1016/j.amjmed.2005.04.010. PMID:15850548.
25. Clifford, M.N. 1999. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. J. Sci. Food Agric. 79: 362-372. doi:10.1002/(SICI)1097-0010(19990301)79:3〈362::AID-JSFA256〉3.0.CO;2-D.
26. Corrao, G., Zambon, A., Bagnardi, V., D'Amicis, A., and Klatsky, A. 2001. Coffee, caffeine, and the risk of liver cirrhosis. Ann. Epidemiol. 11: 458-465. doi:10.1016/S1047-2797(01)00223-X. PMID:11557177.
27. Daglia, M., Tarsi, R., Papetti, A., Grisoli, P., Dacarro, C., Pruzzo, C., and Gazzani, G. 2002. Antiadhesive effect of green and roasted coffee on Streptococcus mutans' adhesive properties on saliva-coated hydroxyapatite beads. J. Agric. Food Chem. 50: 1225-1229. doi:10.1021/jf010958t. PMID:11853508.
28. Davidson, S.M., and Duchen, M.R. 2007. Endothelial mitochondria: contributing to vascular function and disease. Circ. Res. 100: 1128-1141. doi:10.1161/01.RES.0000261970.18328.1d. PMID:17463328.
29. de Paulis, T., Schmidt, D.E., Bruchey, A.K., Kirby, M.T., McDonald, M.P., Commers, P., et al. 2002. Dicinnamoylquinides in roasted coffee inhibit the human adenosine transporter. Eur. J. Pharmacol. 442: 215-223. doi:10.1016/S0014-2999(02)01540-6. PMID:12065074.
30. Dekker, M.J., Gusba, J.E., Robinson, L.E., and Graham, T.E. 2007. Glucose homeostasis remains altered by acute caffeine ingestion following 2 weeks of daily caffeine consumption in previously non-caffeine-consuming males. Br. J. Nutr. 98: 556-562. doi:10.1017/S0007114507730738. PMID:17524180.
31. Dellalibera, O., Lemaire, B., and Lafay, S. 2006. Le Svetol, un extrait de cafe vert decafeine, induit une perte de poids et augmente le ratio masse maigre sure masse grasse chez des volontarires en surcharge ponderale. Phytotherapie, 4: 194-197. doi:10.1007/s10298-006-0181-7.
32. Diaz-Rubio, M.E., and Saura-Calixto, F. 2007. Dietary fiber in brewed coffee. J. Agric. Food Chem. 55: 1999-2003. doi:10.1021/jf062839p. PMID:17295507.
33. Drucker, D.J., and Nauck, M.A. 2006. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 368: 1696-1705. doi:10.1016/S0140-6736(06)69705-5. PMID:17098089.
34. Dulloo, A.G., Geissler, C.A., Horton, T., Collins, A., and Miller, D.S. 1989. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers. Am. J. Clin. Nutr. 49: 44-50. PMID:2912010.
35. Dupas, C.J., Marsset-Baglieri, A.C., Ordonaud, C.S., Ducept, F.M. G., Maillard, M.-N. 2006. Coffee antioxidant properties: effects of milk addition and processing conditions. J. Food Sci. 71: S253-S258. doi:10.1111/j.1750-3841.2006.00075.x.
36. ESHA Research. Diet Analysis Plus. Version 6.1. 2003. Wadsworth Publishing, Salem, Ore.
37. Farah, A., de Paulis, T., Trugo, L.C., and Martin, P.R. 2005. Effect of roasting on the formation of chlorogenic acid lactones in coffee. J. Agric. Food Chem. 53: 1505-1513. doi:10.1021/jf048701t. PMID:15740032.
38. Farah, A., de Paulis, T., Moreira, D.P., Trugo, L.C., and Martin, P.R. 2006. Chlorogenic acids and lactones in regular and water-decaffeinated arabica coffees. J. Agric. Food Chem. 54: 374-381. doi:10.1021/jf0518305. PMID:16417293.
39. Fournier, F. 1948. Plantes Medicinales et Veneneuses de France. Lechevalier Ed. Paris. p. 495.
40. Fredholm, B.B. 1982. Adenosine actions and adenosine receptors after 1 week treatment with caffeine. Acta Physiol. Scand. 115: 283-286. PMID:6291335.
41. Fredholm, B.B., Battig, K., Holmen, J., Nehlig, A., and Zvartau, E.E. 1999. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51: 83-133. PMID:10049999.
42. Fujioka, K., and Shibamoto, T. 2006. Quantitation of volatiles and nonvolatile acids in an extract from coffee beverages: correlation with antioxidant activity. J. Agric. Food Chem. 54: 6054-6058. doi:10.1021/jf060460x. PMID:16881716.
43. Gandhi, S., and Wood, N.W. 2005. Molecular pathogenesis of Parkinson's disease. Hum. Mol. Genet. 14(Spec. No. 2): 2749-2755. doi:10.1093/hmg/ddi308. PMID:16278972.
44. Gibson, F.C., 3rd, Yumoto, H., Takahashi, Y., Chou, H.H., and Genco, C.A. 2006. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J. Dent. Res. 85: 106-121. PMID:16434728.
45. Graham, T.E., Battram, D.S., Dela, F., El-Sohemy, A., and Thong, F.S.L. 2008. Does caffeine alter muscle carbohydrate and fat metabolism during exercise? Appl. Physiol. Nutr. Metab. 33: this issue.
46. Greenberg, J.A., Boozer, C.N., and Geliebter, A. 2006. Coffee, diabetes, and weight control. Am. J. Clin. Nutr. 84: 682-693. PMID:17023692.
47. Greer, F., Hudson, R., Ross, R., and Graham, T. 2001. Caffeine ingestion decreases glucose disposal during a hyperinsulinemiceuglycemic clamp in sedentary humans. Diabetes, 50: 2349-2354. doi:10.2337/diabetes.50.10. 2349. PMID:11574419.
48. Haddy, F.J., Vanhoutte, P.M., and Feletou, M. 2006. Role of potassium in regulating blood flow and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290: R546-R552. PMID:16467502.
49. Health Canada. 2005. Dietary reference intakes: reference values for elements. Available from http://www.hc-sc.gc.ca/fn-an/nutrition/reference/table/ ref_elements_tbl_e.html. [Accessed 15 October 2008.]
50. Health Canada. 2006a. Dietary reference intakes: reference values for macronutrients. Available from http://www.hc-sc.gc.ca/fn-an/nutrition/ reference/table/ref_macronutr_tbl_e.html. [Accessed 15 October 2008.]
51. Health Canada. 2006b. Caffeine. It's your health. Available from http://www.hc-sc.gc.ca/iyh-vsv/food-aliment/caffeine_e.html#he.[Accessed 15 October 2008.]
52. Health Canada. 2006c. Dietary reference intake: reference values of vitamins. Available from http://www.hc-sc.gc.ca/fn-an/nutrition/reference/ table/ref_vitam_tbl_e.html. [Accessed 15 October 2008.]
53. Hemmerle, H., Burger, H.J., Below, P., Schubert, G., Rippel, R., Schindler, P.W., et al. 1997. Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase. J. Med. Chem. 40: 137-145. doi:10.1021/jm9607360. PMID: 9003513.
54. Hetzler, R., Knowlton, R., Somani, S., Brown, D., and Perkins, R. 1990. Effect of paraxanthine on FFA mobilization after intravenous caffeine administration in humans. J. Appl. Physiol. 68: 44-47. PMID:2312486.
55. Higdon, J.V., and Frei, B. 2006. Coffee and health: a review of recent human research. Crit. Rev. Food Sci. Nutr. 46: 101-123. doi:10.1080/10408390500400009. PMID:16507475.
56. Hino, A., Adachi, H., Enomoto, M., Furuki, K., Shigetoh, Y., Ohtsuka, M., et al. 2007. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Res. Clin. Pract. 76: 383-389. doi:10.1016/j.diabres.2006.09.033. PMID:17070955.
57. Honjo, S., Kono, S., Coleman, M.P., Shinchi, K., Sakurai, Y., Todoroki, I., et al. 1999. Coffee drinking and serum gammaglutamyltransferase: an extended study of self-defense officials of Japan. Ann. Epidemiol. 9: 325-331. doi:10.1016/S1047-2797(99)00013-7. PMID:10976859.
58. Honjo, S., Kono, S., Coleman, M.P., Shinchi, K., Sakurai, Y., Todoroki, I., et al. 2001. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J. Clin. Epidemiol. 54: 823-829. doi:10.1016/S0895-4356(01) 00344-4. PMID:11470392.
59. Horst, K., Wilson, R.J., and Smith, R.G. 1936. The effect of coffee and decaffeinated coffee on oxygen consuption, pulse rate and blood pressure. J. Pharmacol. Exp. Ther. 58: 294-304.
60. Hwang, E.S., and Bowen, P.E. 2007. DNA damage, a biomarker of carcinogenesis: its measurement and modulation by diet and environment. Crit. Rev. Food Sci. Nutr. 47: 27-50. doi:10.1080/10408390600550299. PMID:17364694.
61. Johnston, K.L., Clifford, M.N., and Morgan, L.M. 2003. Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am. J. Clin. Nutr. 78: 728-733. PMID:14522730.
62. Keijzers, G.B., De Galan, B.E., Tack, C.J., and Smits, P. 2002. Caffeine can decrease insulin sensitivity in humans. Diabetes Care, 25: 364-369. doi:10.2337/diacare.25.2.364. PMID:11815511.
63. Kono, S., Shinchi, K., Imanishi, K., Todoroki, I., and Hatsuse, K. 1994. Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. Am. J. Epidemiol. 139: 723-727. PMID:7909403.
64. Kovacs, E.M., Lejeune, M.P., Nijs, I., and Westerterp-Plantenga, M.S. 2004. Effects of green tea on weight maintenance after body-weight loss. Br. J. Nutr. 91: 431-437. doi:10.1079/BJN20041061. PMID:15005829.
65. Lee, S., Hudson, R., Kilpatrick, K., Graham, T.E., and Ross, R. 2005. Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care, 28: 566-572. doi:10.2337/diacare.28.3.566. PMID:15735189.
66. Lopez-Garcia, E., van Dam, R.M., Rajpathak, S., Willett, W.C., Manson, J.E., and Hu, F.B. 2006. Changes in caffeine intake and long-term weight change in men and women. Am. J. Clin. Nutr. 83: 674-680. PMID:16522916.
67. McCarty, M.F. 2005. A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk. Med. Hypotheses, 64: 848-853. doi:10.1016/j.mehy.2004.03.037. PMID:15694706.
68. McCusker, R.R., Fuehrlein, B., Goldberger, B.A., Gold, M.S., and Cone, E.J. 2006. Caffeine content of decaffeinated coffee. J. Anal. Toxicol. 30: 611-613. PMID:17132260.
69. Mealey, B.L., and Oates, T.W. 2006. Diabetes mellitus and periodontal diseases. J. Periodontol. 77: 1289-1303. doi:10.1902/jop.2006.050459. PMID:16881798.
70. Meece, J. 2007. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies. Curr. Med. Res. Opin. 23: 933-944. doi:10.1185/030079906X167336. PMID:17407650.
71. Minamisawa, M., Yoshida, S., and Takai, N. 2004. Determination of biologically active substances in roasted coffees using a diode-array HPLC system. Anal. Sci. 20: 325-328. doi:10.2116/analsci.20.325. PMID:15055960.
72. Mishkinsky, J., Joseph, B., and Sulman, F.G. 1967. Hypoglycaemic effect of trigonelline. Lancet, 2: 1311-1312. doi:10.1016/S0140-6736(67)90428-X. PMID:4168640.
73. Murphy, K.G., Dhillo, W.S., and Bloom, S.R. 2006. Gut peptides in the regulation of food intake and energy homeostasis. Endocr. Rev. 27: 719-727. doi:10.1210/er.2005-0011. PMID:17077190.
74. Naismith, D.J., Akinyanju, P.A., Szanto, S., and Yudkin, J. 1970. The effect, in volunteers, of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting. Nutr. Metab. 12: 144-151. PMID:5473379.
75. Narayan, K.M., Boyle, J.P., Thompson, T.J., Sorensen, S.W., and Williamson, D.F. 2003. Lifetime risk for diabetes mellitus in the United States. JAMA, 290: 1884-1890. doi:10.1001/jama.290.14.1884. PMID:14532317.
76. Natella, F., Nardini, M., Giannetti, I., Dattilo, C., and Scaccini, C. 2002. Coffee drinking influences plasma antioxidant capacity in humans. J. Agric. Food Chem. 50: 6211-6216. doi:10.1021/jf025768c. PMID:12358504.
77. Nordlie, R.C., Foster, J.D., and Lange, A.J. 1999. Regulation of glucose production by the liver. Annu. Rev. Nutr. 19: 379-406. doi:10.1146/annurev.nutr.19.1.379. PMID:10448530.
78. Nunes, F.M., and Coimbra, M.A. 2007. Melanoidins from coffee infusions. Fractionation, chemical characterization, and effect of the degree of roast. J. Agric. Food Chem. 55: 3967-3977. doi:10.1021/jf063735h. PMID:17455954.
79. Olthof, M.R., Hollman, P.C.H., and Katan, M.B. 2001. Chlorogenic acid and caffeic acid are absorbed in humans. J. Nutr. 131: 66-71. PMID:11208940.
80. Olthof, M.R., Hollman, P.C., Buijsman, M.N., van Amelsvoort, J.M., and Katan, M.B. 2003. Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J. Nutr. 133: 1806-1814. PMID:12771321.
81. Penckofer, S., Schwertz, D., and Florczak, K. 2002. Oxidative stress and cardiovascular disease in type 2 diabetes: the role of antioxidants and pro-oxidants. J. Cardiovasc. Nurs. 16: 68-85. PMID:11800069.
82. Pischon, N., Heng, N., Bernimoulin, J.P., Kleber, B.M., Willich, S.N., and Pischon, T. 2007. Obesity, inflammation, and periodontal disease. J. Dent. Res. 86: 400-409. PMID:17452558.
83. Pontes Andersen, C.C., Flyvbjerg, A., Buschard, K., and Holmstrup, P. 2007. Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. J. Periodontol. 78: 559-565. doi:10.1902/jop.2007.060358. PMID:17335381.
84. Pulido, R., Hernandez-Garcia, M., and Saura-Calixto, F. 2003. Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur. J. Clin. Nutr. 57: 1275-1282. doi:10.1038/sj.ejcn.1601685. PMID:14506489.
85. Ramalakshmi, K., and Raghavan, B. 1999. Caffeine in coffee: its removal. Why and how? Crit. Rev. Food Sci. Nutr. 39: 441-456. doi:10.1080/ 10408699991279231. PMID:10516914.
86. Richelle, M., Tavazzi, I., and Offord, E. 2001. Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J. Agric. Food Chem. 49: 3438-3442. doi:10.1021/jf0101410. PMID:11453788.
87. Robinson, L.E., Savani, S., Battram, D.S., McLaren, D.H., Sathasivam, P., and Graham, T.E. 2004. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J. Nutr. 134: 2528-2533. PMID:15465742.
88. Roden, M., and Bernroider, E. 2003. Hepatic glucose metabolism in humans - its role in health and disease. Best Pract. Res. Clin. Endocrinol. Metab. 17: 365-383. doi:10.1016/S1521-690X(03)00031-9. PMID:12962691.
89. Rodriguez de Sotillo, D.V., and Hadley, M. 2002. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J. Nutr. Biochem. 13: 717-726. doi:10.1016/S0955-2863(02)00231-0. PMID:12550056.
90. Rudovich, N., Kaiser, S., Engeli, S., Osterhoff, M., Gogebakan, O., Bluher, M., and Pfeiffer, A.F. 2007. GIP receptor mRNA expression in different fat tissue depots in postmenopausal nondiabetic women. Regul. Pept. 142:138-145. PMID: 17395281.
91. Ruhl, C.E., and Everhart, J.E. 2005. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology, 128: 24-32. doi:10.1053/j.gastro.2004. 09.075. PMID:15633120.
92. Salazar-Martinez, E., Willett, W.C., Ascherio, A., Manson, J.E., Leitzmann, M.F., Stampfer, M.J., and Hu, F.B. 2004. Coffee consumption and risk for type 2 diabetes mellitus. Ann. Intern. Med. 140: 1-8. PMID:14706966.
93. Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F.L., Powe, N.R., and Golden, S.H. 2004. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann. Intern. Med. 141: 421-431. PMID:15381515.
94. Sharp, D.S., and Benowitz, N.L. 1995. Re: "Alcohol, smoking, coffee, and cirrhosis" and "coffee and serum gammaglutamyltransferase: a study of self-defense officials in Japan". Am. J. Epidemiol. 141: 480-482. PMID:7879794.
95. Shearer, J., Farah, A., de Paulis, T., Bracy, D.P., Pencek, R.R., Graham, T.E., and Wasserman, D.H. 2003. Quinides of roasted coffee enhance insulin action in conscious rats. J. Nutr. 133: 3529-3532. PMID:14608069.
96. Shearer, J., Sellars, E.A., Farah, A., Graham, T.E., and Wasserman, D.H. 2007. Effects of chronic coffee consuption on glucose kinetics in the conscious rat. Can. J. Physiol. Pharmacol. 85: 823-830. doi:10.1139/Y07-070. PMID:17901893.
97. Shimoda, H., Seki, E., and Aitani, M. 2006. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement. Altern. Med. 6: 9. doi:10.1186/1472-6882-6-9. PMID:16545124.
98. Smith, B., Wingard, D.L., Smith, T.C., Kritz-Silverstein, D., and Barrett-Connor, E. 2006. Does coffee consumption reduce the risk of type 2 diabetes in individuals with impaired glucose? Diabetes Care, 29: 2385-2390. doi:10.2337/dc06-1084. PMID:17065672.
99. Soriguer, F., Rojo-Martinez, G., and de Antonio, I.E. 2004. Coffee consumption and type 2 diabetes mellitus. Ann. Intern. Med. 141: 321-323. [Author reply 323-324.] PMID:15313753.
100. Storey, M.L., Forshee, R.A., and Anderson, P.A. 2006. Beverage consumption in the US population. J. Am. Diet. Assoc. 106: 1992-2000. doi:10.1016/j.jada.2006.09.009. PMID:17126630.
101. Svilaas, A., Sakhi, A.K., Andersen, L.F., Svilaas, T., Strom, E.C., Jacobs, D.R., Jr., et al. 2004. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J. Nutr. 134: 562-567. PMID: 14988447.
102. Tanaka, K., Tokunaga, S., Kono, S., Tokudome, S., Akamatsu, T., Moriyama, T., and Zakouji, H. 1998. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int. J. Epidemiol. 27: 438-443. doi:10.1093/ije/27.3.438. PMID:9698132.
103. Tarnopolsky, M.A. 2008. Effect of caffeine on the neuromuscular system - potential as an ergogenic aid. Appl. Physiol. Nutr. Metab. 33: this issue.
104. Thom, E. 2007. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people. J. Int. Med. Res. 35: 900-908. PMID:18035001.
105. Thong, F.S., Derave, W., Kiens, B., Graham, T.E., Urso, B., Wojtaszewski, J.F., et al. 2002. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise. Diabetes, 51: 583-590. doi:10.2337/diabetes.51.3.583. PMID:11872654.
106. Toft-Nielsen, M.B., Damholt, M.B., Madsbad, S., Hilsted, L.M., Hughes, T.E., Michelsen, B.K., and Holst, J.J. 2001a. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 86: 3717-3723. doi:10.1210/jc.86.8.3717. PMID:11502801.
107. Toft-Nielsen, M.B., Madsbad, S., and Holst, J.J. 2001b. Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes. J. Clin. Endocrinol. Metab. 86: 3853-3860. doi:10.1210/jc.86.8.3853. PMID:11502823.
108. Tunnicliffe, J., Eller, L., Hallam, M., Su, L., and Shearer, J. 2008a. Chlorogenic acid and blood glucose control: the link between coffee and diabetes. Presented at the 1st Alberta Canadian Obesity Network - Student and new professional (CON-SNP) research day: Linking obesity research throughout the province. 20 March 2008, Canadian Obesity Network, Calgary, Alta.
109. Tunnicliffe, J.M., Erdman, K.A., Reimer, R.A., Lun, V., and Shearer, J. 2008b. Consumption of dietary caffeine and coffee in physically active populations: physiological interactions. Appl. Physiol. Nutr. Metab. 33: this issue.
110. Tverdal, A., and Skurtveit, S. 2003. Coffee intake and mortality from liver cirrhosis. Ann. Epidemiol. 13: 419-423. doi:10.1016/S1047-2797(02) 00462-3. PMID:12875799.
111. United States Department of Agriculture. 2006. USDA National Nutrient Database for Standard Reference. Release 19. Available from http://www.nal.usda. gov/fnic/foodcomp/search/. [Accessed 15 October 2008.]
112. van Dam, R.M. 2006. Coffee and type 2 diabetes: from beans to beta-cells. Nutr. Metab. Cardiovasc. Dis. 16: 69-77. doi:10.1016/j.numecd.2005.10. 003. PMID:16399494.
113. van Dam, R.M. 2008. Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl. Physiol. Nutr. Metab. 33: this issue.
114. van Dam, R.M., and Feskens, E.J.M. 2002. Coffee consumption and risk of type 2 diabetes mellitus. Lancet, 360: 1477-1478. doi:10.1016/S0140- 6736(02)11436-X. PMID:12433517.
115. van Dam, R.M., and Hu, F.B. 2005. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA, 294: 97-104. doi:10.1001/jama.294.1. 97. PMID:15998896.
116. van Dam, R.M., Dekker, J.M., Nijpels, G., Stehouwer, C.D., Bouter, L.M., and Heine, R.J. 2004a. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia, 47: 2152-2159. doi:10.1007/s00125-004-1573-6. PMID:15662556.
117. van Dam, R.M., Pasman, W.J., and Verhoef, P. 2004b. Effects of coffee consumption on fasting blood glucose and insulin concentrations: randomized controlled trials in healthy volunteers. Diabetes Care, 27: 2990-2992. doi:10.2337/diacare.27.12.2990. PMID:15562223.
118. Vergauwen, L., Hespel, P., and Richter, E.A. 1994. Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J. Clin. Invest. 93: 974-981. doi:10.1172/JCI117104. PMID:8132783.
119. Viani, R. 1993. The composition of coffee. In Caffeine, coffee, and health. Edited by S. Garattini. Raven Press, New York. pp. 17-41.
120. Vilsboll, T., Krarup, T., Sonne, J., Madsbad, S., Volund, A., Juul, A.G., and Holst, J.J. 2003. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 88: 2706-2713. doi:10.1210/jc.2002-021873. PMID:12788877.
121. Weickert, M.O., and Pfeiffer, A.F. 2006. Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia, 49: 1732-1741. doi:10.1007/s00125-006-0295-3. PMID:16718463.
122. Welsch, C.A., Lachance, P.A., and Wasserman, B.P. 1989. Dietary phenolic compounds: inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles. J. Nutr. 119: 1698-1704. PMID:2600675.
123. Yanagimoto, K., Lee, K.G., Ochi, H., and Shibamoto, T. 2002. Antioxidative activity of heterocyclic compounds found in coffee volatiles produced by Maillard reaction. J. Agric. Food Chem. 50: 5480-5484. doi:10.1021/jf025616h. PMID:12207495.
124. Yanagimoto, K., Ochi, H., Lee, K.G., and Shibamoto, T. 2004. Antioxidative activities of fractions obtained from brewed coffee. J. Agric. Food Chem. 52: 592-596. doi:10.1021/jf030317t. PMID:14759154.
125. Zhang, Y., and Wells, J.N. 1990. The effects of chronic caffeine administration on peripheral adenosine receptors. J. Pharmacol. Exp. Ther. 254: 757-763. PMID:2395110.